By improving the properties of miRNA therapeutics, Mirina's technology presents promising potential for treating a wide range of diseases, including cancers, infectious diseases and various metabolic disorders.Nanogen has developed and patented novel methods for preparing oligonucleotides appended with Minor Groove Binding (MGB) agents---chemical groups that have high affinity for helical DNA or R